PG
GSK icon

PEAK6 Group’s GSK GSK Stock Holding History

PEAK6 Group’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		$11M Sell
218,640
-2,320
-1% -$117K 0.05% 410
2018
Q1 		$10.8M Sell
220,960
-276,720
-56% -$12.9M 0.05% 416
2017
Q4 		$22.1M Buy
497,680
+224,800
+82% +$10.4M 0.1% 207
2017
Q3 		$13.8M Sell
272,880
-92,000
-25% -$4.67M 0.07% 293
2017
Q2 		$19.7M Buy
364,880
+68,240
+23% +$3.64M 0.11% 164
2017
Q1 		$15.6M Buy
296,640
+277,920
+1,485% +$14.1M 0.13% 172
2016
Q4 		$901K Sell
18,720
-24,480
-57% -$1.21M 0.01% 1968
2016
Q3 		$2.33M Sell
43,200
-118,320
-73% -$6.49M 0.02% 1180
2016
Q2 		$8.75M Buy
161,520
+34,480
+27% +$1.82M 0.07% 392
2016
Q1 		$6.44M Buy
127,040
+5,040
+4% +$251K 0.05% 494
2015
Q4 		$6.15M Sell
122,000
-164,080
-57% -$8.36M 0.04% 604
2015
Q3 		$13.8M Buy
286,080
+254,640
+810% +$13.3M 0.07% 343
2015
Q2 		$1.64M Sell
31,440
-7,760
-20% -$437K 0.01% 1639
2015
Q1 		$2.26M Sell
39,200
-21,680
-36% -$1.24M 0.02% 1182
2014
Q4 		$3.25M Buy
60,880
+49,360
+428% +$2.76M 0.02% 934
2014
Q3 		$662K Buy
11,520
+8,400
+269% +$515K 0.01% 2209
2014
Q2 		$209K Buy
3,120
+2,720
+680% +$184K ﹤0.01% 3171
2014
Q1 		$27K Buy
+400
New +$27K ﹤0.01% 4499
2013
Q4 		– Sell
-46,400
Closed -$1.46M – 5079
2013
Q3 		$1.46M Sell
46,400
-27,520
-37% -$1.77M 0.01% 1822
2013
Q2 		$4.62K Buy
+73,920
New +$4.69M 0.02% 814

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

PEAK6 Group's GSK Position: Q1 2018 in Review

PEAK6 Group sold out of GSK (GSK) in Q1 2018, closing a stake of 170,371 shares — an estimated $7.93M sold.

PEAK6 Group first reported a position in GSK in Q2 2013 and held it in 8 quarters. The position peaked at $7.55M in Q4 2017. 778 funds tracked by Wall St. Rank hold GSK as of Q1 2018.

  • PEAK6 Group reported no remaining GSK position as of Q1 2018 after selling out during the quarter.
  • PEAK6 Group sold 170,371 GSK shares in Q1 2018, an estimated $7.93M.
  • PEAK6 Group first reported a position in GSK in Q2 2013 and held it in 8 quarters.
  • PEAK6 Group's GSK position peaked at $7.55M in Q4 2017.
  • 778 funds tracked by Wall St. Rank held GSK as of Q1 2018.

Based on PEAK6 Group's 13F filing for Q1 2018, filed 15 May 2018.